🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
80.96
-0.42 (-0.52%)
At close: Nov 20, 2026, 4:00 PM EST
81.12
+0.16 (0.20%)
After-hours: Nov 20, 2026, 7:42 PM EST

BioNTech SE Stock Forecast

Stock Price Forecast

According to 21 analysts polled by S&P Global, BioNTech SE stock has a consensus rating of "Buy" and an average price target of $112.22. The average 1-year stock price forecast is 38.61% higher than the current stock price, while the lowest is $74.38 (-8.13%) and the highest is $143.8 (+77.62%).

Price Target: $112.22 (+38.61%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$74.38$112.22$108.14$143.8
Change-8.13%+38.61%+33.57%+77.62%

Analyst Ratings

The average analyst rating for BioNTech SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy141414131313
Buy111111
Hold554577
Sell001100
Strong Sell000000
Total202020202121

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Hold
Reiterates
$92 → $93
HoldReiterates$92 → $93+14.87%Nov 19, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
$108
BuyMaintains$108+33.40%Nov 17, 2026
Citi
Citi
Buy
Maintains
$125
BuyMaintains$125+54.40%Nov 11, 2026
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$106
BuyReiterates$106+30.93%Nov 9, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$130 → $110
BuyReiterates$130 → $110+35.87%Nov 9, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.85B
from 2.87B
Decreased by -35.39%
Revenue Next Year
1.85B
from 1.85B
Decreased by -0.40%
EPS This Year
-5.09
from -0.48
EPS Next Year
-4.73
from -5.09
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
18.98B17.31B3.82B2.75B2.87B1.85B
Revenue Growth
3,834.63%-8.78%-77.94%-27.96%4.32%-35.39%
Gross Profit
16.07B14.32B3.22B2.21B2.26B1.54B
Gross Margin
84.66%82.70%84.29%80.32%78.70%82.85%
Operating Income
14.85B11.92B971.80M-1.29B-1.27B-1.87B
Net Income
10.29B9.43B930.30M-665.30M-1.14B-1.53B
EPS
-----0.48-5.09
Free Cash Flow
----280.90M-1.23B
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High2.1B
Avg1.9B
Low1.8B

Revenue Growth

Revenue Growth202620272028
High
-27.3%
Avg
-35.4%
Low
-37.6%

EPS Forecast

EPS202620272028
High-4.18
Avg-5.09
Low-6.11

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-